Evidence map›Paper›PMID 23493554›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2013

Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.

Hong-Ying Wang, Chi A Ma, Yongge Zhao, Xiying Fan, Qing Zhou, Pamela Edmonds, Gulbu Uzel, Joao Bosco Oliveira, Jordan Orange, Ashish Jain

Open access · bronzeAbstract readCase ReportsClinical Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Monogenic etiologies of persistent human papillomavirus infections: A comprehensive systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Membrane lymphotoxin-αCell death & disease · 2021
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. B Cell Disorders in Children: Part II.Current allergy and asthma reports · 2020
    Review
  17. Article
  18. Primary B-cell immunodeficiencies.Human immunology · 2019
    Review
  19. Review
  20. Liability of sepsis is hardly determined by the COXI variant m.6459T>C.Journal of cellular and molecular medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Hong-Ying WangLaboratory of Host Defenses, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Chi A Ma
Yongge Zhao
Xiying Fan
Qing Zhou
Pamela Edmonds
Gulbu Uzel
Joao Bosco Oliveira
Jordan Orange
Ashish Jain
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USNational Human Genome Research Institute · USUniversity of Pennsylvania · US

Funding

The Genetics, Pathogenesis, and Treatment of Primary ImmunodeficiencyZIAAI000924 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI JAIN, ASHISH · 2009 to 2013
$4.8M
Intramural NIH HHS
6 · The paper itself

Abstract

Mutations in the TNF family of proteins have been associated with inherited forms of immune deficiency. Using an array-based sequencing assay, we identified an autosomal-dominant deficiency in TNF-like weak inducer of apoptosis (TWEAK; TNFSF12) in a kindred with recurrent infection and impaired antibody responses to protein and polysaccharide vaccines. This mutation occurs in the sixth exon of TWEAK and results in the amino acid substitution R145C within the conserved TNF-homology domain of the full-length protein. TWEAK mutant protein formed high molecular weight aggregates under nonreducing conditions, suggesting an increased propensity for intermolecular interactions. As a result, mutant TWEAK associated with B-cell-activating factor (BAFF) protein and down-regulated the BAFF-mediated activation of the noncanonical NF-κB pathway through inhibition of p100 processing to p52, resulting in inhibition of BAFF-dependent B-cell survival and proliferation. As BAFF mediates T-cell-independent isotype switching and B-cell survival, our data implicate TWEAK as a disease-susceptibility gene for a humoral immunodeficiency.

Indexed as

Genetic Predisposition to DiseaseMutation, MissenseAdultAmino Acid SubstitutionB-Cell Activating FactorB-LymphocytesCell ProliferationCell SurvivalChildChild, PreschoolCytokine TWEAKDown-RegulationFemaleGenetic Diseases, InbornHumansImmunologic Deficiency SyndromesB-Cell Activating FactorCytokine TWEAKNF-kappa B p52 SubunitTNFSF12 protein, humanTNFSF13B protein, humanTumor Necrosis Factors

Identifiers

PMID23493554
PMCPMC3612633
OpenAlexW2028351685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.